Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy

Objective: identification of peptides in the composition of Laennec®, which can inhibit the development of endotheliopathy (endothelial dysfunction).Material and methods. Hybrid mass spectrometry followed by data analysis based on topological recognition theory was performed. The analysis of the pep...

Full description

Saved in:
Bibliographic Details
Main Authors: I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-01-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/625
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050206177951744
author I. Yu. Torshin
О. А. Gromova
V. G. Zgoda
А. G. Chuchalin
V. А. Maksimov
О. V. Tikhonova
author_facet I. Yu. Torshin
О. А. Gromova
V. G. Zgoda
А. G. Chuchalin
V. А. Maksimov
О. V. Tikhonova
author_sort I. Yu. Torshin
collection DOAJ
description Objective: identification of peptides in the composition of Laennec®, which can inhibit the development of endotheliopathy (endothelial dysfunction).Material and methods. Hybrid mass spectrometry followed by data analysis based on topological recognition theory was performed. The analysis of the peptide composition of Laennec® included four stages: purification of the drug, chromatographic separation of peptides, determination of the multidimensional mass spectrum of the peptide fraction, and de novo sequencing of the isolated peptides.Results. The preparation contains peptides-inhibitors of specific target proteins (PRKCZ, PKB, PKD1, MAPK14, IKKB, PDPK1) involved in the activation of the pro-inflammatory transcription factor NF-κB. Inhibition of CDK5 and SHC1 kinases helps to reduce endothelial cell apoptosis. The peptides of the drug also block enzymes involved in the synthesis and maturation of the tumor necrosis factor alpha (MAPKAPK2/3, ADAM17).Conclusion. In the composition of Laennec®, peptides have been found that contribute to a complex pathogenetic action against endotheliopathy. Endothelial regeneration is especially important in the rehabilitation of patients who have recovered from COVID-19.
format Article
id doaj-art-536ecf7e8b634a1d8fa6883e29636be7
institution DOAJ
issn 2070-4909
2070-4933
language Russian
publishDate 2022-01-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj-art-536ecf7e8b634a1d8fa6883e29636be72025-08-20T02:53:31ZrusIRBIS LLCФармакоэкономика2070-49092070-49332022-01-0114446847910.17749/2070-4909/farmakoekonomika.2021.114367Peptides of Laennec® preparation that contribute to the elimination of endotheliopathyI. Yu. Torshin0О. А. Gromova1V. G. Zgoda2А. G. Chuchalin3V. А. Maksimov4О. V. Tikhonova5Federal Research Center “Informatics and Management”, Russian Academy of SciencesFederal Research Center “Informatics and Management”, Russian Academy of SciencesOrekhovich Research Institute of Biomedical Chemistry, Center for Collective Use “Human Proteome”Pirogov Russian National Research Medical UniversityRussian Medical Academy of Continuing Professional EducationOrekhovich Research Institute of Biomedical Chemistry, Center for Collective Use “Human Proteome”Objective: identification of peptides in the composition of Laennec®, which can inhibit the development of endotheliopathy (endothelial dysfunction).Material and methods. Hybrid mass spectrometry followed by data analysis based on topological recognition theory was performed. The analysis of the peptide composition of Laennec® included four stages: purification of the drug, chromatographic separation of peptides, determination of the multidimensional mass spectrum of the peptide fraction, and de novo sequencing of the isolated peptides.Results. The preparation contains peptides-inhibitors of specific target proteins (PRKCZ, PKB, PKD1, MAPK14, IKKB, PDPK1) involved in the activation of the pro-inflammatory transcription factor NF-κB. Inhibition of CDK5 and SHC1 kinases helps to reduce endothelial cell apoptosis. The peptides of the drug also block enzymes involved in the synthesis and maturation of the tumor necrosis factor alpha (MAPKAPK2/3, ADAM17).Conclusion. In the composition of Laennec®, peptides have been found that contribute to a complex pathogenetic action against endotheliopathy. Endothelial regeneration is especially important in the rehabilitation of patients who have recovered from COVID-19.https://www.pharmacoeconomics.ru/jour/article/view/625endothelial dysfunctionproteomicscoronavirus infectionpolypeptide therapy
spellingShingle I. Yu. Torshin
О. А. Gromova
V. G. Zgoda
А. G. Chuchalin
V. А. Maksimov
О. V. Tikhonova
Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
Фармакоэкономика
endothelial dysfunction
proteomics
coronavirus infection
polypeptide therapy
title Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
title_full Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
title_fullStr Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
title_full_unstemmed Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
title_short Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
title_sort peptides of laennec r preparation that contribute to the elimination of endotheliopathy
topic endothelial dysfunction
proteomics
coronavirus infection
polypeptide therapy
url https://www.pharmacoeconomics.ru/jour/article/view/625
work_keys_str_mv AT iyutorshin peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy
AT oagromova peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy
AT vgzgoda peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy
AT agchuchalin peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy
AT vamaksimov peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy
AT ovtikhonova peptidesoflaennecpreparationthatcontributetotheeliminationofendotheliopathy